$CVS 4/A SEC Filings

Filed On	Filing
09 May 2025	Form 4/A: Joyner J. David, Director Received 53,324 shares as a grant or award
26 Dec 2024	Form 4/A: Joyner J. David, Director Granted 1,000,000 Premium Stock Option ($71.8M) · Granted 492,537 Premium Stock Appreciation Right ($35.4M)
14 Oct 2022	Form 4/A: Clark James David, SVP, Cont & Chief Acct Officer Gave up 266 shares to cover exercise price or tax ($23.6K)
30 Jun 2022	Form 4/A: Chaguturu Sreekanth K, EVP and Chief Medical Officer Received 0 shares as a grant or award
30 Jun 2022	Form 4/A: Shah Prem S, EVP and Co-President of Retail Received 0 shares as a grant or award
07 Apr 2020	Form 4/A: Mayhew Jonathan E., EVP, Chief Transformation Off Granted 28,159 Stock Option
07 Apr 2020	Form 4/A: Lynch Karen S, EVP & Pres, Aetna Bus Unit Granted 211,196 Stock Option
07 Apr 2020	Form 4/A: Flum Joshua Matthew, EVP, ENT STRATEGY & DIGITAL Granted 63,358 Stock Option
07 Apr 2020	Form 4/A: Lotvin Alan, EVP, Transformation Granted 140,797 Stock Option
07 Apr 2020	Form 4/A: Bisaccia Lisa, EVP and Chief HR Officer Granted 98,558 Stock Option
07 Apr 2020	Form 4/A: Brennan Troyen A, EVP and Chief Medical Officer Granted 112,637 Stock Option
07 Apr 2020	Form 4/A: Moriarty Thomas M, EVP & General Counsel Granted 197,116 Stock Option
07 Apr 2020	Form 4/A: Boratto Eva C, EVP & CFO Granted 168,956 Stock Option
07 Apr 2020	Form 4/A: Roberts Jonathan C, EVP & Chief Operating Officer Granted 239,355 Stock Option
07 Apr 2020	Form 4/A: Merlo Larry J, Director Granted 478,711 Stock Option
12 Apr 2019	Form 4/A: Flum Joshua Matthew, EVP, Ent. Strategy & Digital Gave up 990 shares to cover exercise price or tax ($57.3K) · Received 1,268 shares as a grant or award ($73.3K) · Received 2,297 shares as a grant or award ($133K)
12 Apr 2019	Form 4/A: Flum Joshua Matthew, EVP, Ent. Strategy & Digital Gave up 742 shares to cover exercise price or tax ($40.2K) · Granted 60,602 Stock Option ($3.28M)
16 Mar 2018	Form 4/A: Denton David M, EVP and CFO Disposed of 1,851 shares (Other Transaction) ($125K)
27 May 2016	Form 4/A: Foulkes Helena, EVP, President-CVS Pharmacy Gave up 2,199 shares to cover exercise price or tax ($230K)
12 Feb 2013	Form 4/A: Denton David M, EVP, CFO Received 11,526 shares by exercise or conversion ($346K)

Comments